Literature DB >> 21491187

Computer-assisted design for paracetamol masking bitter taste prodrugs.

Hatem Hejaz1, Rafik Karaman, Mustafa Khamis.   

Abstract

It is believed that the bitter taste of paracetamol, a pain killer drug, is due to its hydroxyl group. Hence, it is expected that blocking the hydroxy group with a suitable linker could inhibit the interaction of paracetamol with its bitter taste receptor/s and hence masking its bitterness. Using DFT theoretical calculations we calculated proton transfers in ten different Kirby's enzyme models, 1-10. The calculation results revealed that the reaction rate is linearly correlated with the distance between the two reactive centers (r(GM)) and the angle of the hydrogen bonding (α) formed along the reaction pathway. Based on these results three novel tasteless paracetamol prodrugs were designed and the thermodynamic and kinetic parameters for their proton transfers were calculated. Based on the experimental t(1/2) (the time needed for the conversion of 50% of the reactants to products) and EM (effective molarity) values for processes 1-10 we have calculated the t(1/2) values for the conversion of the three prodrugs to the parental drug, paracetamol. The calculated t(1/2) values for ProD 1-3 were found to be 21.3 hours, 4.7 hours and 8 minutes, respectively. Thus, the rate by which the paracetamol prodrug undergoes cleavage to release paracetamol can be determined according to the nature of the linker of the prodrug (Kirby's enzyme model 1-10). Further, blocking the phenolic hydroxyl group by a linker moiety is believed to hinder the paracetamol bitterness.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21491187     DOI: 10.1007/s00894-011-1040-5

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  12 in total

1.  Relationship between rate and distance.

Authors:  Fredric M Menger; Ashley L Galloway; Djamaladdin G Musaev
Journal:  Chem Commun (Camb)       Date:  2003-09-21       Impact factor: 6.222

2.  Computer-assisted design of pro-drugs for antimalarial atovaquone.

Authors:  Rafik Karaman; Hussein Hallak
Journal:  Chem Biol Drug Des       Date:  2010-08-20       Impact factor: 2.817

3.  The effective molarity (EM)--a computational approach.

Authors:  Rafik Karaman
Journal:  Bioorg Chem       Date:  2010-04-10       Impact factor: 5.275

4.  The effective molarity (EM) puzzle in proton transfer reactions.

Authors:  Rafik Karaman
Journal:  Bioorg Chem       Date:  2009-05-05       Impact factor: 5.275

5.  A new mathematical equation relating activation energy to bond angle and distance: A key for understanding the role of acceleration in lactonization of the trimethyl lock system.

Authors:  Rafik Karaman
Journal:  Bioorg Chem       Date:  2008-10-25       Impact factor: 5.275

6.  Efficient intramolecular general acid catalysis of nucleophilic attack on a phosphodiester.

Authors:  Anthony J Kirby; Marcelo F Lima; Davi da Silva; Christo D Roussev; Faruk Nome
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

7.  Stereopopulation control. I. Rate enhancement in the lactonizations of 0-hydroxyhydrocinnamic acids.

Authors:  S Milstien; L A Cohen
Journal:  J Am Chem Soc       Date:  1972-12-27       Impact factor: 15.419

8.  Rate acceleration by stereopopulation control: models for enzyme action.

Authors:  S Milstien; L A Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1970-11       Impact factor: 11.205

9.  A computational analysis of intramolecularity in proton transfer reactions.

Authors:  Rafik Karaman; Robert Pascal
Journal:  Org Biomol Chem       Date:  2010-09-17       Impact factor: 3.876

10.  T2Rs function as bitter taste receptors.

Authors:  J Chandrashekar; K L Mueller; M A Hoon; E Adler; L Feng; W Guo; C S Zuker; N J Ryba
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

View more
  7 in total

1.  Design, synthesis and in vitro kinetic study of tranexamic acid prodrugs for the treatment of bleeding conditions.

Authors:  Rafik Karaman; Hiba Ghareeb; Khuloud Kamal Dajani; Laura Scrano; Hussein Hallak; Saleh Abu-Lafi; Gennaro Mecca; Sabino A Bufo
Journal:  J Comput Aided Mol Des       Date:  2013-07-24       Impact factor: 3.686

2.  Computationally designed prodrugs of statins based on Kirby's enzyme model.

Authors:  Rafik Karaman; Wajd Amly; Laura Scrano; Gennaro Mecca; Sabino A Bufo
Journal:  J Mol Model       Date:  2013-07-09       Impact factor: 1.810

3.  Prodrugs for masking bitter taste of antibacterial drugs--a computational approach.

Authors:  Rafik Karaman
Journal:  J Mol Model       Date:  2013-02-19       Impact factor: 1.810

4.  Computer-assisted design for atenolol prodrugs for the use in aqueous formulations.

Authors:  Rafik Karaman; Khuloud Dajani; Hussein Hallak
Journal:  J Mol Model       Date:  2011-07-23       Impact factor: 1.810

5.  Prodrugs of fumarate esters for the treatment of psoriasis and multiple sclerosis--a computational approach.

Authors:  Rafik Karaman; Ghadeer Dokmak; Maryam Bader; Hussein Hallak; Mustafa Khamis; Laura Scrano; Sabino Aurelio Bufo
Journal:  J Mol Model       Date:  2012-09-02       Impact factor: 1.810

Review 6.  Enzyme Models-From Catalysis to Prodrugs.

Authors:  Zeinab Breijyeh; Rafik Karaman
Journal:  Molecules       Date:  2021-05-28       Impact factor: 4.411

7.  Design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations.

Authors:  Rafik Karaman; Alaa Qtait; Khulod Khayyat Dajani; Saleh Abu Lafi
Journal:  ScientificWorldJournal       Date:  2014-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.